相关实验视频
Updated: May 22, 2025

09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
14.4K
通过用病毒模拟疫苗调节淋巴结中的先天细胞微环境来增强免疫反应
Runping Su1,2, Tingting Yao1, Chong Cao1,3
1Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Pudong Hospital, Key Laboratory of Medical Molecular Virology of MOE/NHC/CAMS, School of Basic Medical Sciences, Fudan University, 131 Dong An Road, Shanghai, 200032, P.R. China.
Angewandte Chemie (International ed. in English)
|March 12, 2025
概括
病毒模拟疫苗 (VMVs) 通过调节淋巴结中的先天细胞微环境来增强免疫反应. 这种新型纳米疫苗平台可以增强幽默和细胞免疫力,以预防传染病.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 纳米疫苗显示出有前途的效果,但由于缺少先天和适应性免疫刺激,它们往往难以应对.
- 有效的纳米疫苗设计需要增强免疫细胞激活和协调的策略.
研究的目的:
- 开发一个多功能纳米疫苗平台,称为病毒模拟疫苗 (VMVs),用于增强免疫反应的产生.
- 研究VMVs调节淋巴结 (LNs) 内的先天细胞微环境的能力,以提高疫苗的疗效.
主要方法:
- 通过将聚氨酸标记的抗原组装到含有氨酸-氨酸-氨酸 oligodeoxynucleotide 的核酸纳米凝上,开发出 VMV.
- 使用盐桥式拉链机制进行非共价组装和Toll-like受体9激活.
- 通过肌内免疫接种给予VMV,并分析LNs内的先天细胞招募,激活和转移.
主要成果:
- 在LNs中,VMVs有效地招募和激活各种先天性免疫细胞 (DCs,巨细胞,中性粒细胞).
- 天生的细胞激活导致了LN微环境的调节,并优化了抗原呈现细胞功能.
- 诱导强大的抗原特异性免疫反应,包括高中和抗体,记忆T细胞活性和生殖中心B细胞发育.
结论:
- VMVs代表了一种合理的疫苗策略,用于动态调节先天细胞微环境.
- 这种方法优化了针对传染病的幽默性和细胞性免疫的产生.
- VMV为开发下一代纳米疫苗提供了一个有前途的平台.
相关概念视频
Immune Response Against Viral Pathogens
722
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
722
Vaccinations
43.3K
Overview
43.3K
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
Cell-mediated Immune Responses
66.6K
Overview
66.6K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
B Cell Activation and Differentiation
1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K

